FDA approves Eli Lilly’s alzheimer’s drug
The drug is targeted at adults in the mild cognitive impairment or mild dementia stage
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Study
GLP-1R agonist withdrawal effect on weight loss and cardiovascular risks remains unmet need:…
Zepbound is Eli Lilly’s new glucagon-like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) dual agonist, approved by the FDA…
Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19: Study
This study was conducted in Europe and India to examine the effects of giving patients injectable 12 mg versus 6 mg of…
Shingles vaccine reduces risk of stroke and heart attack from virus: Study
Results are based on analysis of data from 278,375 adults in New Zealand who got the vaccine between April 2018 and July 2021.…
Development of universal influenza vaccines gaining precedence: GlobalData
The current influenza vaccines only provide protection against a limited number of strains
Exim Bank study highlights priority focus areas, policy initiatives for sectors including pharma
The study titled ‘Domestic Constraints for Exports in Select Sectors’, analyses and highlights policy constraints and common areas…
Researchers identify immune system variation linked to severe COVID-19 cases
The current study found that one risk factor was the presence of an immune system molecule called alpha interferon-a cytokine…
Researchers decode neurological symptoms of coronavirus infection
The scientists said further studies involving brain scans and testing of CNS tissue will be crucial to understanding the…
Study reveals immunotherapy after chemotherapy slows metastatic bladder cancer
The randomised Phase 2 trial tested this treatment in 108 patients. The results of the clinical trial led by Mount Sinai…
Scientists unlock X-Files DNA mystery
Sheffield scientists capture snapshots of enzymes trimming branched DNA after cell division
Scientists have unlocked a crucial…